A pair of scientists at the University of Texas at El Paso is one step closer to developing the first ever clinical Chagas disease vaccine. Researchers Rosa Maldonado, PhD, and Igor Almeida, PhD, both faculty in the Department of Biological Sciences, recently were granted a patent for “Mucin-Associated Surface Protein As Vaccine Against Chagas Disease.”
Chagas is caused by the parasite Trypanosoma cruzi, which is transmitted to animals and people by insect vectors known as kissing bugs. The bugs are shown in these lab dishes. Courtesy of JR Hernandez, UTEP Communications
A pair of scientists at the University of Texas at El Paso is one step closer to developing the first ever clinical Chagas disease vaccine. Researchers Rosa Maldonado, PhD, and Igor Almeida, PhD, both faculty in the Department of Biological Sciences, recently were granted a patent for “Mucin-Associated Surface Protein As Vaccine Against Chagas Disease.”
“We dream of this [a vaccine for Chagas disease], but we don’t know it is going to happen,” Almeida said. “You dream to get something to help the people and you expect to make at least a small contribution,” Maldonado shared.
The preventive vaccine had been in development since 2008 and most recently was tested at the Texas Biomedical Research Institute (TBRI) in San Antonio on nonhuman primates in collaboration with John VandeBerg, PhD. Results are promising and may lead to clinical trials in the coming years.
A second vaccine, based on synthetic parasite sugars, in collaboration with Katja Michael, PhD, associate professor in the Department of Chemistry at UTEP, also was tested in nonhuman primates at TBRI and yielded very promising results. Almeida started work on that vaccine 27 years ago and is currently awaiting patent approval. The vaccine studies were funded by the Kleberg Foundation and the National Institutes of Health.
“The big problem with Chagas disease is heart failure,” Maldonado explained. “We have determined the inflammation in the heart and the parasitic load significantly decreased, and this vaccine is protecting the animals from the disease. These are the first synthetic vaccines tested in a non-human primate model ever.”
The UTEP scientists said that 6 million to 8 million people are chronically infected with the potentially life-threatening Chagas disease. Chagas is caused by the parasite Trypanosoma cruzi, which is transmitted to animals and people by insect vectors known as kissing bugs. The disease has been endemic in Latin America, but is rapidly spreading through the U.S., Europe and other nonendemic regions as a result of globalization. Yet, there is no clinical vaccine, although there have been several experimental efforts throughout the years.
Both UTEP researchers confirm kissing bugs are in the Paso del Norte region that includes El Paso, have been caught and tested, and many turn out positive with Trypanosoma cruzi. The number of people infected, though, is underreported because symptoms may take decades to turn up and doctors don’t regularly test for this tropical disease.
“It is not like a viral infection; you don’t see it, you feel like you have the flu,” Almeida said. “After several years is when you start having problems. Seventy to 80 percent of those infected don’t feel anything until they start having cardiac problems or gastrointestinal issues or both. That can take over 10-20 years.”
Getting it from a kissing bug isn’t the only way to contract the disease. Once a human is infected, the parasite can be transmitted to others via organ transplants, blood transfusions and from a mother to a fetus. In addition, the parasite can be spread through foods and juices tainted by the contaminated bug feces.
To prevent parasite transmission by the kissing bug, the scientists say it’s important to be aware of the presence of the bugs in the house and yard.
“If you see kissing bugs, do not touch them. You can collect them using gloves and a jar. To prevent them from coming into your home, plug any cracks in your home, keep screens on your windows and doors and make sure there are no tears,” the pair advised.
If you catch a kissing bug, call 915-747-6891 or 915-747-6086 or email ramaldonado@utep.edu or icalmeida@utep.edu so their team can pick up the specimen and test it.
Efforts are under way now to increase community awareness locally and seek funding for future studies.
“We feel good but would feel better if these vaccines went on to clinical trials,” Almeida said. “The anxiety to go to the next step is unbearable,” Maldonado added. “Every step is a very hard fight.”
Source: University of Texas at El Paso
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.
What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness
July 16th 2025Despite their smooth, polished exteriors, surgical instruments often harbor dangerous contaminants deep inside their lumens. At the HSPA25 and APIC25 conferences, Cori L. Ofstead, MSPH, and her colleagues revealed why borescopes are an indispensable tool for sterile processing teams, offering the only reliable way to verify internal cleanliness and improve sterile processing effectiveness to prevent patient harm.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.